CONTINUE OUR VIRTUAL
MARCH ON WASHINGTON
PLEASE CO-SIGN OUR
OPEN LETTER TO ROBERT W. PATTERSON
ACTING DIRECTOR, U.S. DRUG ENFORCEMENT ADMINISTRATION
Dear Administrator Patterson,
We the undersigned, Americans who join the millions of our fellow citizens who responsibly use the botanical plant kratom as a part of our health and well-being regimens, join the American Kratom Association (AKA) in strongly urging the Drug Enforcement Administration (DEA) to conduct a thorough and independent 8-Factor Analysis on kratom to test the credibility of the scheduling recommendation submitted by the US Food and Drug Administration (FDA).
In its enactment of the Controlled Substances Act, Congress has wisely required the DEA to do its own independent review on scheduling recommendations submitted by the FDA to provide a 2nd opinion on important substance scheduling issues. That 2nd opinion is desperately needed in the evaluation of kratom because the science directly refutes the FDA claims.
Specifically, we respectfully ask the DEA to carefully examine the following issues in its own 8-Factor Analysis on kratom:
- Kratom is a safe botanical that does not kill people. The deaths the FDA claims are caused by kratom are actually fatalities associated with underlying health issues of the decedent, or caused by the use of other toxic doses of substances that are co-administered or mixed with kratom. Kratom has a long history of safe use over centuries when responsibly consumed, and the FDA claims are simply unsupportable based on the science.
- If kratom is banned, opioid deaths will increase. The opioid crisis in America kills more than 90 people every day. Credible studies show that many people manage pain using kratom as an alternative to dangerously addictive and potentially deadly prescription opioids. If it is banned, those people will be forced to opioid use, or to the black market for products that are contaminated or adulterated, and therefore very dangerous. The perverse public health outcome from any ban on kratom will result in more deaths.
- Kratom is an alternative to opioids, not a gateway to opioid abuse. Kratom does not produce a high like opioids; kratom does not suppress the respiratory system like opioids; and kratom does not produce opioid-like effects. Kratom is safely and responsibly used by millions of Americans, including some for alleviating pain. Without kratom, many will be forced to opioid use to alleviate pain.
- The AKA, and we agree, strongly supports appropriate FDA regulations to protect consumers. Protecting consumers from adulterated and contaminated kratom products; assuring children cannot purchase or consume kratom; imposing good manufacturing standards to ensure product purity; product packaging standards to prevent tampering; and clear labeling and health claims restrictions similar to other dietary supplement products, are important roles for the FDA to have in protecting consumer safety, and we welcome such restrictions to ensure continued safe and responsible use of kratom products by consumers.
The DEA has received an independent 8-Factor Analysis on kratom authored by one of the leading experts on addiction and substance safety, Jack Henningfield, Ph.D., and we believe that data will be critically important to the DEA’s own analysis of kratom. In addition, there are four other key studies on kratom use that the DEA should consider that clearly demonstrate the harm that will be done by any scheduling order on kratom.